Context Therapeutics Inc. (CNTX)

AI Score

Unlock

0.93

0.10 (11.51%)

At close: Apr 22, 2025, 12:57 PM

Context Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net Income	-26.73M	-30.15M	-18.57M	-21.32M	-23.96M	-20.75M	-18.73M	-17.71M	-14.84M	-14.37M	-11.96M	-13M	-10.46M	-8.15M	-7.58M	4.93M	6.64M	7.43M	8.31M	826.48K
Depreciation & Amortization	10.88K	10.52K	10.79K	11.42K	12.04K	12.67K	12.77K	12.46K	9.27K	6.07K	2.88K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	841.87K	866.1K	908.04K	1.03M	1.08M	1.06M	1.09M	1.04M	976.44K	937.18K	822.49K	700.52K	511.08K	337.52K	206.51K	117.79K	219.25K	188.43K	157.61K	126.97K
Other Working Capital	-2.53M	-1.57M	-139.94K	-266.62K	57.2K	1.25M	-756.35K	-422.03K	510.37K	-775.94K	-1.05M	-1.1M	-1.36M	373K	1.42M	1.21M	762.03K	399.35K	113.88K	-55.73K
Other Non-Cash Items	17.02M	16.7M	1.94M	318.67K	-242.05K	73.75K	87.73K	586.58K	578.52K	538.5K	392.68K	3.33M	3.37M	3.4M	3.75M	-7.84M	-9.22M	-9.23M	-9.46M	-1.33M
Deferred Income Tax	n/a	294.02K	294.02K	294.02K	294.02K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-3.48M	-2.37M	-763.91K	568.49K	1.78M	1.85M	260.87K	605.23K	-277.52K	-1.69M	-889.32K	-1.93M	-2.22M	393.82K	-697.8K	230.27K	1.32M	755.6K	485.56K	185.65K
Operating Cash Flow	-14.56M	-16.88M	-18.4M	-19.68M	-21.05M	-17.75M	-17.28M	-15.46M	-13.55M	-14.58M	-11.63M	-10.9M	-8.8M	-4.01M	-4.32M	-2.56M	-1.03M	-858.6K	-508.39K	-187.35K
Capital Expenditures	-7.32K	-7.32K	4.00	n/a	n/a	n/a	-500K	-501.84K	-536.84K	-536.84K	-36.84K	-35K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-14.75M	-14.75M	n/a	n/a	n/a	n/a	-500K	-500K	-500K	-750K	-250K	-500K	-500K	-250K	-250K	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-14.76M	-14.76M	n/a	n/a	n/a	n/a	-500K	-501.84K	-536.84K	-786.84K	-286.84K	-535K	-500K	-250K	-250K	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	124.05K	149.05K	149.05K	149.05K	25K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	94.8M	94.8M	94.8M	n/a	n/a	n/a	-102.07K	-102.07K	-204.14K	54.02M	53.31M	53.31M	53.41M	-816.92K	n/a	200K	200K	200K	200K	n/a
Financial Cash Flow	109.29M	94.76M	94.8M	n/a	n/a	n/a	-102.07K	-102.07K	-204.14K	54.02M	53.31M	55.26M	58.39M	4.52M	5.78M	4.16M	1.15M	799.05K	349.05K	25K
Net Cash Flow	79.98M	63.12M	76.4M	-19.68M	-21.05M	-17.75M	-17.78M	-15.96M	-14.19M	39.01M	41.64M	44.07M	49.34M	252.09K	1.21M	1.6M	114.43K	-59.54K	-159.34K	-162.35K
Free Cash Flow	-4.91M	-7.23M	-18.4M	-19.68M	-21.05M	-17.75M	-17.78M	-15.96M	-14.09M	-15.12M	-11.67M	-10.94M	-8.8M	-4.01M	-4.32M	-2.56M	-1.03M	-858.6K	-508.39K	-187.35K